Search for Clinical Trial Results

Sponsored By

Hemorrhagic Fever, Ebola - 25 Studies Found

Status Study
Completed Study Name: Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
Condition: Hemorrhagic Fever, Ebola
Date: 2014-10-31
Interventions: Biological: rVSVΔ-ZEBOV-GP single dose of rVSVΔ-ZEBOV-GP (3x10^6 pfu, 2x10^7 pfu or 3x10^5)
Completed Study Name: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)
Condition: Hemorrhagic Fever, Ebola
Date: 2015-02-19
Interventions: Biological: rVSVΔG-ZEBOV The rVSVΔG-ZEBOV vaccine is comprised of a single recombinant VSV iso
Active, not recruiting Study Name: Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
Condition: Hemorrhagic Fever, Ebola
Date: 2015-01-29
Interventions:
  • Biological: cAd3-EBOZ cAd3 vac
Recruiting Study Name: Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo
Condition: Hemorrhagic Fever, Ebola
Date: 2016-01-08
Interventions:
  • Biological: Ad26.ZEBOV No vacc
Recruiting Study Name: Safety, Tolerability and Immunogenicity Study of 2 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo
Condition: Hemorrhagic Fever, Ebola
Date: 2015-11-04
Interventions:
  • Biological: Ad26.ZEBOV One 0.5
Completed Study Name: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
Condition: Hemorrhagic Fever, Ebola
Date: 2015-01-12
Interventions: Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients.
Completed Study Name: Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects
Condition: Ebola
Date: 2015-02-10
Interventions:
  • Biological: Base Dose EBOV GP Vaccine
  • Biol
Recruiting Study Name: Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
Condition: Hemorrhagic Fever, Ebola
Date: 2015-09-29
Interventions:
  • Biological: Ad26.ZEBOV One 0.5
Active, not recruiting Study Name: Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
Condition: Ebola Virus
Date: 2015-01-22
Interventions:
  • Biological: VSVG-ZEBOV The VSV
Recruiting Study Name: A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo
Condition:
  • Ebola
  • Ebola Zaire

Date: 2014-09-10
Interventions:
  • Biological: cAd3-EBO Z at 1 x 10^10 vp

Next >>>